Pfizer, Inc. (PFE) Earnings Call Analysis
NYSE · Healthcare · Drug Manufacturers - General
Next earnings call: 2026-08-04
(Q2 2026)
— full calendar
Earnings Reports
-
Pfizer (PFE) Q1 2026: New Products Drive 22% Growth, Post-2028 Revenue Trajectory Strengthens
May 05, 2026
-
Pfizer (PFE) Q4 2025: Non-COVID Portfolio Grows 9% as Obesity Pipeline Targets $150B Market
February 03, 2026
-
Pfizer (PFE) 2026 Guidance: $17B LOE Headwind Drives Margin Compression, Obesity Pipeline Anchors Post-2028 Growth
December 17, 2025
-
Pfizer (PFE) Q3 2025: Non-COVID Products Grow 4% as $7.7B Cost Savings Target Drives Margin Strength
November 04, 2025
-
Pfizer (PFE) Q2 2025: New Launches Drive $4.7B, Margin Expansion Signals Post-LOE Resilience
August 05, 2025
-
Pfizer (PFE) Q2 2025: New Products Deliver $4.7B, Margin Expansion Accelerates Pipeline Bets
August 05, 2025
-
Pfizer (PFE) Q1 2025: $7.7B Cost Savings Target Sharpens Margin Focus Amid Tariff Uncertainty
July 01, 2025